INS and Alzheimer disease: This reduced insulin response may lead to increased glycogen synthase kinase-3 (GSK-3) activity, which is involved in the hyperphosphorylation of tau, Aβ production, neuroinflammation, glial activation, apoptotic neuronal death, and memory impairment in AD [7,129,138,139].